Global trends of antimicrobial susceptibility to ceftaroline and ceftazidime–avibactam: a surveillance study from the ATLAS program (2012–2016)

BACKGROUND: This study reports the global trends of antimicrobial susceptibility to ceftaroline and ceftazidime–avibactam using data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program between 2012 and 2016. METHODS: For the 2012–2016 ATLAS program, 205 medical centers located...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hui, Xu, Yingchun, Jia, Peiyao, Zhu, Ying, Zhang, Ge, Zhang, Jingjia, Duan, Simeng, Kang, Wei, Wang, Tong, Jing, Ran, Cheng, Jingwei, Liu, Yali, Yang, Qiwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590473/
https://www.ncbi.nlm.nih.gov/pubmed/33109242
http://dx.doi.org/10.1186/s13756-020-00829-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590473/
https://www.ncbi.nlm.nih.gov/pubmed/33109242
http://dx.doi.org/10.1186/s13756-020-00829-z

Ejemplares similares